Hypertrophic cardiomyopathy trials in Brazil

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Enrolling by invitation
  Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

  Where

  Belo Horizonte, Bragança Paulista, Campinas, Ribeirão Preto, São Paulo

  Age

  18 years to 85 years

  People

  900 worldwide

  Run by

  Cytokinetics

  See details and how to joinNCT04848506 · EU 2023-508963-58-00
• No phaseTaking people
  National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

  Where

  Belém, Belo Horizonte, Bragança Paulista, Brasília, Consolação, Fortaleza, Goiânia, Joinville, Macapá, Maceió, Montes Claros, Natal, Palmas, Porto Alegre, Porto Velho, Rio Branco, Rio de Janeiro, Salvador, São Carlos, São Paulo, Vila Velha

  People

  1,211

  Run by

  Hospital do Coracao

  See details and how to joinNCT06546137